About EvidScience
EvidScience is a company based in El Segundo (United States) founded in 2016 was acquired by Genesis Research in January 2021. EvidScience has raised $500 thousand across 2 funding rounds from investors including Tikehau Capital, Genesis Research and Wavemaker 360. EvidScience operates in a competitive market with competitors including Veeva Systems, Sygnature Discovery, Instem, Dotmatics and Strateos, among others.
- Headquarter El Segundo, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$500 K (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Tikehau Capital
& 3 more
-
Employee Count
Not available
-
Acquired by
Genesis Research
(Jan 07, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of EvidScience
EvidScience has successfully raised a total of $500K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EvidScience
EvidScience has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Tikehau Capital, Genesis Research and Wavemaker 360.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Accelerator and venture capital firm
|
Locked | Locked | Locked | |
|
Debt and equity investments are managed by the private fund.
|
Locked | Locked | Locked |
Investor details for EvidScience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EvidScience
Investment portfolio details for EvidScience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EvidScience
Detailed financials for EvidScience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Evidscience Comparisons
Peer comparison for EvidScience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EvidScience
EvidScience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Veeva Systems, Sygnature Discovery, Instem, Dotmatics and Strateos, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based data management solutions for healthcare are provided.
|
|
| Locked | Locked | Locked |
Services and products for integrated drug discovery are provided.
|
|
| Locked | Locked | Locked |
Software for life science data collection and analysis is provided.
|
|
| Locked | Locked | Locked |
AI powered scientific data management and workflow automation solutions
|
|
| Locked | Locked | Locked |
Provider of cloud based platform provides data driven information for biotech research
|
|
| Locked | Locked | Locked |
Databases and analytics for drug discovery are provided.
|
Detailed competitors of EvidScience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Evidscience
Complete news archive for EvidScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EvidScience
EvidScience was founded in 2016 and raised its 1st funding round 2 years after it was founded.
EvidScience is headquartered in El Segundo, United States. It is registered at El Segundo, California, United States.
EvidScience is a funded company, having raised a total of $500K across 2 funding rounds to date.
EvidScience has developed a machine learning-based platform which can analyze data available in peer-reviewed articles to generate insights and summaries of cost and outcomes related data. The company claims that its platform can generate 500X faster than humans. The company can analyze data and provide outcomes with respect to brand insights, competitive landscapes, clinical study design optimization, and real-time cost analysis.
EvidScience's top competitors include Veeva Systems, Dotmatics and Sygnature Discovery.
EvidScience has 4 investors. Key investors include Tikehau Capital, Genesis Research, Wavemaker 360, and Mucker.